Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
暂无分享,去创建一个
M. Khan | M. Gheorghiade | S. Anker | J. Butler | G. Fonarow | H. Khan | S. Greene
[1] Qi Zhang,et al. Effects of renin–angiotensin–aldosterone system inhibitors on mortality, hospitalization, and diastolic function in patients with HFpEF , 2016, Herz.
[2] G. Rada,et al. Are angiotensin-converting enzyme inhibitors or angiotensin 2 receptor antagonists effective in heart failure with preserved ejection fraction? , 2015, Medwave.
[3] M. Komajda,et al. Controversies in cardiovascular medicine Heart failure with preserved ejection fraction : a clinical dilemma , 2014 .
[4] Sanjiv J. Shah,et al. The Emerging Epidemic of Heart Failure with Preserved Ejection Fraction , 2013, Current Heart Failure Reports.
[5] M. Gheorghiade,et al. Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction. , 2013, The American journal of medicine.
[6] L. Lund,et al. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. , 2012, JAMA.
[7] M. Gheorghiade,et al. Angiotensin receptor blockers and outcomes in real‐world older patients with heart failure and preserved ejection fraction: a propensity‐matched inception cohort clinical effectiveness study , 2012, European journal of heart failure.
[8] J. Ge,et al. Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies. , 2012, International journal of cardiology.
[9] R. McKelvie,et al. Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction: Findings From the I-PRESERVE Trial , 2011, Circulation. Heart failure.
[10] W. Hundley,et al. A Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction: Effects on Exercise Tolerance and Arterial Distensibility , 2010, Circulation. Heart failure.
[11] C. D. Andrews,et al. A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction , 2009, European journal of heart failure.
[12] Susan Anderson,et al. Irbesartan in patients with heart failure and preserved ejection fraction. , 2008, The New England journal of medicine.
[13] Z. Massy,et al. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. , 2008, The American journal of cardiology.
[14] J. Sanderson,et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction , 2008, Heart.
[15] R. McKelvie,et al. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. , 2007, Journal of the American College of Cardiology.
[16] J. McMurray. Renin angiotensin blockade in heart failure with preserved ejection fraction: The signal gets stronger. , 2006, European heart journal.
[17] Peter C Austin,et al. Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.
[18] V. Roger,et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.
[19] J. González-Juanatey,et al. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study. , 2006, Journal of cardiac failure.
[20] N. Freemantle,et al. Perindopril for elderly people with chronic heart failure: the PEP‐CHF study , 1999, European heart journal.
[21] M. Redfield,et al. Epidemiology of diastolic heart failure. , 2005, Progress in cardiovascular diseases.
[22] M. Lye,et al. The Effect of Quinapril on Functional Status of Elderly Patients with Diastolic Heart Failure , 2003, Cardiovascular Drugs and Therapy.
[23] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.
[24] E. Philbin,et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. , 2000, The American journal of medicine.
[25] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[26] E. Philbin,et al. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. , 1997, American heart journal.
[27] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.